Bristol Myers Squibb (BMY) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $6.5 billion.
- Bristol Myers Squibb's Other Non-Current Assets rose 604.42% to $6.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.5 billion, marking a year-over-year increase of 604.42%. This contributed to the annual value of $6.5 billion for FY2025, which is 604.42% up from last year.
- As of Q4 2025, Bristol Myers Squibb's Other Non-Current Assets stood at $6.5 billion, which was up 604.42% from $6.3 billion recorded in Q3 2025.
- In the past 5 years, Bristol Myers Squibb's Other Non-Current Assets registered a high of $7.4 billion during Q3 2021, and its lowest value of $4.7 billion during Q2 2022.
- For the 5-year period, Bristol Myers Squibb's Other Non-Current Assets averaged around $5.8 billion, with its median value being $5.9 billion (2025).
- In the last 5 years, Bristol Myers Squibb's Other Non-Current Assets tumbled by 3590.44% in 2022 and then soared by 2374.69% in 2024.
- Quarter analysis of 5 years shows Bristol Myers Squibb's Other Non-Current Assets stood at $5.5 billion in 2021, then fell by 10.75% to $4.9 billion in 2022, then rose by 8.7% to $5.4 billion in 2023, then increased by 13.69% to $6.1 billion in 2024, then grew by 6.04% to $6.5 billion in 2025.
- Its last three reported values are $6.5 billion in Q4 2025, $6.3 billion for Q3 2025, and $5.9 billion during Q2 2025.